DrugSupplement
Sarcosine clinical trials
- studies test it
- 9
- open now
- 0
- in phase 3
- 0
- first study started
- 2004
How studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
9 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 7
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 9
China Medical University Hospital (5) · Medical University of Lodz (1) · Chang-Hua Hospital (1) · Massachusetts General Hospital (1) · Herzog Hospital (1)
Often tested with
Tested in the same studies.
Beryllium (1) · D-serine zwitterion (1)
Studies
Open first, then newest update. How each study uses Sarcosine is read from its arms, and is right about nine times in ten.
Testing it · 9
- Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in SchizophreniaCompletedPhase 2Medical University of LodzNCT01503359Written as Sarcosine
- Treatment of N-methyl-D-aspartate (NMDA) Enhancers for SchizophreniaCompletedPhase 2Chang-Hua HospitalNCT01047592Written as sarcosine
- Sarcosine Preventive Therapy for Individuals At High Risk for SchizophreniaWithdrawnPhase 2Herzog HospitalNCT00276263Written as Sarcosine (N-methylglycine)
- The Impact of Pharmacological and Electric Modulation of NMDA Pathway on the Cognitive Flexibility and Volitional Movement Preparation in Patients With Parkinson's DiseaseCompletedNot applicableChina Medical University HospitalNCT01785628Written as Sarcosine Capsule
- A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With SchizophreniaCompletedNot applicableMassachusetts General HospitalNCT00538070Written as Sarcosine
- N-methylglycine (Sarcosine) Treatment for DepressionCompletedPhase 2China Medical University HospitalNCT00977353Written as sarcosine
- N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)CompletedPhase 2China Medical University HospitalNCT01031927Written as N-methyl glycine
- Sarcosine or D-Serine Add-on Treatment for Chronic SchizophreniaCompletedPhase 2China Medical University HospitalNCT00491569Written as Sarcosine and D-serine
- Sarcosine (N-Methylglycine) Monotherapy for SchizophreniaCompletedPhase 2China Medical University HospitalNCT00328276Written as Sarcosine
Codes
What other systems call Sarcosine · ClinicalTrials.gg INT008180
- MeSH (NLM) D012521SarcosineConfirmed NLM, Wikidata
- UNII (FDA) Z711V88R5FSARCOSINEConfirmed FDA, NLM, Wikidata
- RxNorm 1362906Confirmed FDA, Wikidata
- Wikidata Q106345645sarcosine zwitterionConfirmed FDA, NLM, Wikidata
- Wikidata Q414157sarcosineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C113501SarcosineOne source FDA
- DrugBank DB12519One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D012521 | Sarcosine | Confirmed NLM, Wikidata |
| UNII (FDA) | Z711V88R5F | SARCOSINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1362906 | — | Confirmed FDA, Wikidata |
| Wikidata | Q106345645 | sarcosine zwitterion | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q414157 | sarcosine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C113501 | Sarcosine | One source FDA |
| DrugBank | DB12519 | — | One source Wikidata |
Also registered as sarcosine hydrochloride (UNII W50V8R1ZE9) and sodium sarcosinate (UNII 6EHN3PQL8Z · RxNorm 1364526).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.